Transthyretin RNA profiling in livers from transplanted patients affected by familial amyloidotic polyneuropathy, and identification of a dual transcription start point

Liver International

Volumn 26, Issue 2, 2006, Pages 211-220

  Rimessi, Paola ^a   Spitali, Pietro ^a   Ando, Yukio ^b   Mazzaferro, Vincenzo ^c   Pastorelli, Francesca ^d   Tassinari, Carlo Alberto ^d   Calzolari, Elisa ^a   Salvi, Fabrizio ^d   Ferlini, Alessandra ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b KUMAMOTO UNIVERSITY   (Japan)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Familial amyloidotic polyneuropathy; Liver; Mutations; RNA; Transcription; Transthyretin

Indexed keywords

PREALBUMIN; RNA;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FAMILIAL AMYLOID POLYNEUROPATHY; FETUS; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA ANALYSIS; SEQUENCE ANALYSIS;

AMYLOID NEUROPATHIES, FAMILIAL; ANIMALS; BASE SEQUENCE; FEMALE; FETUS; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; LIVER TRANSPLANTATION; MALE; MOLECULAR SEQUENCE DATA; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREALBUMIN; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY; TRANSCRIPTION, GENETIC;

EID: 33645960125     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01208.x     Document Type: Article

References (37)

1. Herbert J, Wilcox J N, Pham K T, Fremeau R T Jr, Zeviani M, Dwork A, et al. Transthyretin: A choroid plexus-specific transport protein in human brain. The 1986S. Weir Mitchell award. Neurology 1986; 36: 900-11.
2. Benson M D, Uemichi T. Transthyretin amyloidosis. Int J Exp Clin Invest 1996; 3: 44-56.
3. Tsuzuki T, Mita S, Maeda S, Araki S, Shimada K. Structure of the human prealbumin gene. J Biol Chem 1985; 260: 12224-7.
4. Duan W, Achen M G, Richardson S J, Lawrence M C, Wettenhall R E, Jaworowski A, et al. Isolation, characterisation, cDNA cloning and gene expression of an avian transthyretin. Eur J Biochem 1991; 200: 679-87.
5. Sundelin J, Melhus H, Das S, Eriksson U, Lind P, Tragardh L, et al. The primary structure of rabbit and rat prealbumin and a comparison with the tertiary structure of human prealbumin. J Biol Chem 1985; 25: 6481-7.
6. Achen M G, Duan W, Pettersson T M, Harms P J, Richardson S J, Lawrence M C, et al. Transthyretin gene expression in choroid plexus first evolved in reptiles. Am J Physiol 1993; 265: R982-9.
7. Saraiva M J. Transthyretin amyloidosis: A tale of weak interactions. FEBS Lett 2001; 498 (2-3): 201-3, review.
8. Saraiva M J. Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat 2001; 17 (6): 493-503, review.
9. Plante-Bordeneuve V, Said G. Transthyretin related familial amyloid polyneuropathy. Curr Opin Neurol 2000; 13 (5): 569-73, review.
10. Ferlini A, Fini S, Salvi F, Patrosso M C, Vezzoni P, Forabosco A. Molecular strategies in genetic diagnosis of transthyretin-related hereditary amyloidosis. FASEB J 1992; 6: 2864-6.
11. Andrade C. A peculiar form of peripheral neuropathy: Familial atypical generalised amyloidosis with special involvement of the peripehral nerves. Brain 1952; 52 (75): 408-27.
12. Hammarstrom P, Wiseman R L, Powers E T, Kelly J W. Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 2003; 31 (5607): 713-6.
13. Jaroniec C P, Macphee C E, Astrof N S, Dobson C M, Griffin R G. Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril. Proc Natl Acad Sci USA 2002; 24 (26): 16748-53.
14. Simmons Z, Blaivas M, Aguilera A J, Feldman E L, Bromberg M B, Towfighi J. Low diagnostic yield of sural nerve biopsy in patient with peripheral neuropathy and primary Amyloidosis. J Neurol Sci 1993; 120: 60-3.
15. Sousa M M, Cardoso I, Fernandes R, Guimaraes A, Saraiva M J. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am J Pathol 2001; 159 (6): 1993-2000.
16. Fiori M G, Salvi F, Plasmati R, Tessari F, Bianchi R, Tassinari C A. Amyloid deposits inside myocardial fibers in transthyretin-Met30 familial amyloidotic polyneuropathy. A histological and biochemical study. Cardiology 1994; 85 (3-4): 145-53.
17. Otto M, Hansen T, Kriegsmann J. Images in cardiology: Intracellular cardiac amyloidosis in familiar amyloid polyneuropathy of the Portuguese type. Heart 2002; 88 (1): 90.
18. Sousa M M, Saraiva M J. Internalization of transthyretin. Evidence of a novel yet unidentified receptor-associated protein (RAP)-sensitive receptor. J Biol Chem 2001; 276 (17): 14420-5.
19. Holmgren G, Ericzon B G, Groth C G, Steen L, Suhr O, Andersen O, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993; 1 (8853): 1113-6.
20. Suhr O B, Ericzon B G, Friman S. Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transpl 2002; 8 (9): 787-94.
21. Samadani U, Qian X, Costa R H. Identification of a transthyretin enhancer site that selectively binds the hepatocyte nuclear factor-3 beta isoform. Gene Expr 1996; 6 (1): 23-33.
22. Nagata Y, Tashiro F, Yi S, Murakami T, Maeda S, Takahashi K, et al. A 6-Kb upstream region of the human transthyretin gene can direct developmental. tissue specific, and quantitatively normal expression in transgenic mouse. J Biochem 1995; 117: 169-75.
23. Motojima K, Goto S. Dual promoters and tissue-specific expression of rat transthyretin gene. Biochem Biophys Res Commun 1990; 173 (1): 323-30.
24. Ferlini A, Obici L, Manzati E, Biadi O, Tarantino E, Conigli P, et al. Mutation and transcription analysis of transthyretin gene in Italian families with hereditary amyloidosis: A putative novel hot spot in codon 47. Clin Genet 2000; 57 (4): 284-90.
25. Chomczynsky P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 1987; 162: 156-9.
26. Loughna S, Bennett P, Moore G. Molecular analysis of the expression of transthyretin in intestine and liver from trisomy 18 fetuses. Hum Genet 1995; 95: 89-95.
27. Soares M L, Centola M, Chae J, Saraiva M J, Kastner D L. Human transthyretin intronic open reading frames are not independently expressed in vivo or part of functional transcripts. Biochim Biophys Acta 2003; 1626 (1-3): 65-74.
28. Larsen L K, Amri E Z, Mandrup S, Pacot C, Kristiansen K. Genomic organization of the mouse peroxisome proliferator-activated receptor beta/delta gene: Alternative promoter usage and splicing yield transcripts exhibiting differential translational efficiency. Biochem J 2002; 366 (Part 3): 767-75.
29. Anney R J, Rees M I, Bryan E, Spurlock G, Williams N, Norton N, et al. Characterisation, mutation detection, and association analysis of alternative promoters and 5′ UTRs of the human dopamine D3 receptor gene in schizophrenia. Mol Psychiatry 2002; 7 (5): 493-502.
30. Whetstine J R, Flatley R M, Matherly L H. The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: Identification of seven non-coding exons and characterization of a novel promoter. Biochem J 2002; 367 (Part 3): 629-40.
31. Kominato Y, Hata Y, Takizawa H, Matsumoto K, Yasui K, Tsukada J, et al. Alternative promoter identified between a hypermethylated upstream region of repetitive elements and a CpG island in human ABO histo-blood group genes. J Biol Chem 2002; 277 (40): 37936-48.
32. Newton D C, Bevan S C, Choi S, Robb G B, Millar A, Wang Y, et al. Translational regulation of human neuronal nitric-oxide synthase by an alternatively spliced 5′-untranslated region leader exon. J Biol Chem 2003; 278 (1): 636-44.
33. Mao J, Chirala S S, Wakil S J. Human acetyl-CoA carboxylase 1 gene: presence of three promoters and heterogeneity at the 5′-untranslated mRNA region. Proc Natl Acad Sci USA 2003; 100 (13): 7515-20.
34. Landry J R, Mager D L. Widely spaced alternative promoters, conserved between human and rodent, control expression of the Opitz syndrome gene MID1. Genomics 2002; 80 (5): 499-508.
35. Walsh N C, Cahill M, Carninci P, Kawai J, Okazaki Y, Hayashizaki Y, et al. Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene. Gene 2003; 307: 111-23.
36. Kirigiti P, Bai Y, Yang Y F, Li X, Li B, Brewer G, et al. Agonist-mediated down-regulation of rat beta1-adrenergic receptor transcripts: Role of potential post-transcriptional degradation factors. Mol Pharmacol 2001; 60: 1308-24.
37. Michelotti G A, Bauman M J, Smith M P, Schwinn D A. Cloning and characterization of the rat alpha 1a-adrenergic receptor gene promoter. Demonstration of cell specificity and regulation by hypoxia. J Biol Chem 2003; 278: 8693-705.